Parametric Portfolio Associates’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Parametric Portfolio Associates's AGL Position: Q1 2022 in Review
Parametric Portfolio Associates reduced its Agilon Health (AGL) stake by 22% in Q1 2022, selling an estimated $606K and leaving 4,108 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2279.
Parametric Portfolio Associates first reported a position in AGL in Q4 2021 and has held it in 2 quarters since. The position peaked at $3.57M in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.
- Parametric Portfolio Associates held 4,108 shares of Agilon Health worth $2.6M as of Q1 2022.
- Parametric Portfolio Associates sold 1,175 Agilon Health shares in Q1 2022, an estimated $606K.
- Agilon Health made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2279 holding.
- Parametric Portfolio Associates first reported a position in Agilon Health in Q4 2021 and has held it in 2 quarters since.
- Parametric Portfolio Associates's Agilon Health position peaked at $3.57M in Q4 2021.
- 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.